Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma
Open Access
- 1 January 1993
- Vol. 71 (1) , 231-236
- https://doi.org/10.1002/1097-0142(19930101)71:1<231::aid-cncr2820710136>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Evaluation of a test system for measuring cytokine production in human whole blood cell culturesJournal of Immunological Methods, 1991
- The Prognostic Significance of Recall Antigen Testing in Melanoma PatientsThe Lancet Healthy Longevity, 1987
- The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-upCancer, 1983
- An analysis of skin tests and their relationship to recurrence and survival in stage III and stage IV melanoma patientsCancer, 1982
- DNCB reactivity and prognosis in 419 patients with malignant melanomaCancer, 1981
- A prospective study of immune responsiveness in human melanoma.I. Assessment of initial pretreatment status with stage of diseaseCancer, 1978
- In vitro assessment of immunocompetence in patients with malignant melanomaInternational Journal of Cancer, 1977
- Distribution of Latex-Ingesting Cells, T Cells, and BCells in the Peripheral Blood of Patients With Malignant Melanoma23JNCI Journal of the National Cancer Institute, 1975
- Humoral and cell-mediated immune response in patients with malignant melanoma.I. In vitro lymphocyte reactivity to pha and antigens following immunizationCancer, 1975
- Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapyBritish Journal of Cancer, 1975